Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL699431 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Hydrochloric Acid SCHEMBL699430 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Bromide SCHEMBL699324 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Bromide SCHEMBL699325 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Fluoride Ion SCHEMBL700881 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Iodide SCHEMBL702155 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Fluoride SCHEMBL700882 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Iodide SCHEMBL702154 | 0.96 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTTP53THRB | |
| Benzene SCHEMBL31091106 | 0.96 | ALDH1A1 (0.50) | ALDH1A1LMNAMAPTTP53THRB | |
| SCHEMBL143876 | 0.96 | ALDH1A1 (0.50) | ALDH1A1LMNAMAPTTP53THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4808282-A | REPLACEMENT OF ALKALI METAL IN LIQUID ELECTROLYTE COMPOUND WITH ALKALI EARTH METAL | THE DOW CHEMICAL COMPANY (US) | 1989-02-28 | — | — | US | claimed |
| US-12633572-B2 | Electrolytic solution and electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260121221-A1 | ELECTRODE ASSEMBLY STRUCTURE, SECONDARY BATTERY, AND METHODS OF MANUFACTURE | ENOVIX CORP (US) | 2026-04-30 | — | — | US | disclosed |
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| US-12494507-B2 | Flame retardants for battery electrolytes | ALBEMARLE CORPORATION (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250364653-A1 | BATTERY CELLS HAVING ELECTRODE ASSEMBLIES AND METHODS OF THEIR FABRICATION | ENOVIX CORP (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250349852-A1 | SECONDARY BATTERY | MURATA MANUFACTURING CO (JP) | 2025-11-13 | — | — | US | disclosed |
| US-12451561-B2 | Electrode assembly structure, secondary battery, and methods of manufacture | ENOVIX CORPORATION (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250309351-A1 | ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4599503-A2 | ELECTRODE ASSEMBLIES FOR SECONDARY BATTERIES THAT INCLUDE CURRENT LIMITERS | Enovix Corporation (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20190058209-A1 | NEGATIVE ELECTRODE FOR MAGNESIUM SECONDARY BATTERIES AND METHOD FOR PRODUCING SAME, AND MAGNESIUM SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2019-02-21 | — | — | US | disclosed |
| US-20180138552-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| EP-3319164-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Murata Manufacturing Co., Ltd. (JP) | 2018-05-09 | — | — | EP | disclosed |
| US-20170162908-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3168916-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE | Sony Corporation (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-20150364792-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-1741693-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | NAGOYA IND SCIENCE RES INST (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-4808282-A | REPLACEMENT OF ALKALI METAL IN LIQUID ELECTROLYTE COMPOUND WITH ALKALI EARTH METAL | THE DOW CHEMICAL COMPANY (US) | 1989-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | ALDH1A1 277/4885LMNA 3010/4885MAPT 2709/4885 |
| US-12633572-B2 | Electrolytic solution and electrochemical device | KCNN1, HCN4, KCNN2 | ALDH1A1 668/4885LMNA 4255/4885MAPT 2414/4885 |
| US-20260121221-A1 | ELECTRODE ASSEMBLY STRUCTURE, SECONDARY BATTERY, AND METHODS OF MANUFACTURE | SLC9A2, SLC8A1, GJB2 | ALDH1A1 3086/4885LMNA 435/4885MAPT 1235/4885 |
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | ALDH1A1 2350/4885LMNA 4178/4885MAPT 3159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.